Evidence map›Paper›PMID 41423641›Full record

ArticleNature communications2025

Integrating protein language and geometric deep learning models for enhanced vaccine antigen prediction.

Xiaodong Zai, Yunxiang Zhao, Xiaolin Wang, Mingyue Leng, Menglong Lu, Yilong Yang, Xiaofan Zhao, Ruihua Li, Yaohui Li, Yue Zhang and 5 more

Abstract read
In one paragraph

Article in Nature communications, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Xiaodong Zai *Laboratory of Advanced Biotechnology, Beijing Institute of Biotechnology, Beijing, China.ORCID http://orcid.org/0000-0003-4383-0760
Yunxiang Zhao *Laboratory of Advanced Biotechnology, Beijing Institute of Biotechnology, Beijing, China.ORCID http://orcid.org/0000-0001-6065-811X
Xiaolin WangLaboratory of Advanced Biotechnology, Beijing Institute of Biotechnology, Beijing, China.
Mingyue LengCollege of Computer, National University of Defence Technology, Changsha, China.
Menglong LuCollege of Computer, National University of Defence Technology, Changsha, China.
Yilong YangLaboratory of Advanced Biotechnology, Beijing Institute of Biotechnology, Beijing, China.ORCID http://orcid.org/0000-0003-3412-0425
Xiaofan ZhaoLaboratory of Advanced Biotechnology, Beijing Institute of Biotechnology, Beijing, China.
Ruihua LiLaboratory of Advanced Biotechnology, Beijing Institute of Biotechnology, Beijing, China.ORCID http://orcid.org/0000-0001-9645-5226
Yaohui LiLaboratory of Advanced Biotechnology, Beijing Institute of Biotechnology, Beijing, China.
Yue ZhangLaboratory of Advanced Biotechnology, Beijing Institute of Biotechnology, Beijing, China.
Jun ZhangLaboratory of Advanced Biotechnology, Beijing Institute of Biotechnology, Beijing, China.ORCID http://orcid.org/0000-0002-9650-112X
Dongsheng LiCollege of Computer, National University of Defence Technology, Changsha, China.
Hongguang RenLaboratory of Advanced Biotechnology, Beijing Institute of Biotechnology, Beijing, China. bioren@163.com.ORCID http://orcid.org/0000-0002-9151-6090
Junjie XuLaboratory of Advanced Biotechnology, Beijing Institute of Biotechnology, Beijing, China. xujunjie@sina.com.ORCID http://orcid.org/0000-0001-5456-837X
Wei ChenLaboratory of Advanced Biotechnology, Beijing Institute of Biotechnology, Beijing, China. cw0226@foxmail.com.ORCID http://orcid.org/0000-0001-5805-2469

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Vaccines are the most effective tool in preventing and managing infectious diseases. One of the critical challenges in vaccine development is the selection of suitable target antigens from the thousands of proteins produced by pathogens. Artificial intelligence is anticipated to play a significant role in addressing this challenge. In this study, we develop a framework termed PLGDL for protective antigen prediction that employs Protein Language and Geometric Deep Learning models. This framework leverages both primary sequence features and three-dimensional structural features of protein antigens, thereby reducing the biases associated with manually curated features. Our integrated model exhibits robustness across both constructed and public datasets and is applicable to viruses, bacteria, and eukaryotic pathogens. Notably, when applied to the ongoing Mpox outbreak, our model not only quickly identifies multiple known antigens but also discovers a protective antigen: G10R. Here, our study provides a high-performance screening tool for protective vaccine antigen prediction by synergistically utilizing the capabilities of protein language and geometric deep learning models, providing substantive insights and methodological advancements for rapid vaccine development.

Indexed as

AntigensDeep LearningVaccine DevelopmentVaccinesComputational BiologyHumansAntigensVaccines

Identifiers

PMID41423641
PMCPMC12847940

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.